Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Fluticasone Propionate in Children With Asthma
NCT00163410Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2003
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Forced Expiratory Volume in 1 Second (Absolute Values) at 12 weeks. Started Apr 2003; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00163410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163410.